On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Sankt-Antonius-Hospital Eschweiler

InstitutionResearch output, impact & collaborations

Sankt-Antonius-Hospital Eschweiler is a institution indexed in ScholarIQ from OpenAlex.

What is known about Sankt-Antonius-Hospital Eschweiler?

ScholarIQrecord summary

Sankt-Antonius-Hospital Eschweiler is a research organisation in Eschweiler, DE. OpenAlex records 1,013 works and 48,624 citations for it. 159 researchers list it as their most recent affiliation.

How many works does Sankt-Antonius-Hospital Eschweiler have?

ScholarIQindexed works

Sankt-Antonius-Hospital Eschweiler has 1,013 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Sankt-Antonius-Hospital Eschweiler have?

ScholarIQcitation count

Sankt-Antonius-Hospital Eschweiler has 48,624 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Sankt-Antonius-Hospital Eschweiler?

ScholarIQresearcher count

Sankt-Antonius-Hospital Eschweiler has 159 researchers in the ScholarIQ index.

What is the average h-index at Sankt-Antonius-Hospital Eschweiler?

ScholarIQavg h-index

Sankt-Antonius-Hospital Eschweiler has an average h-index of 66 in OpenAlex.

What is the ROR of Sankt-Antonius-Hospital Eschweiler?

ScholarIQror

The ROR for Sankt-Antonius-Hospital Eschweiler is on the source record.

What is the OpenAlex record for Sankt-Antonius-Hospital Eschweiler?

ScholarIQopenalex

The OpenAlex for Sankt-Antonius-Hospital Eschweiler is on the source record.

Who are the most-cited researchers behind Sankt-Antonius-Hospital Eschweiler?

ScholarIQtop researchers by citations
1
Peter Staib · Acute Myeloid Leukemia Research
296 works20,780 citations

What are the most-cited papers on Sankt-Antonius-Hospital Eschweiler?

ScholarIQmost cited works
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson, AM Fink, R. Busch, Jiřı́ Mayer, M. Hensel, Georg Hopfinger, G Hess, Ulrich von Grünhagen, Michèle Bergmann, J. Catalano, Pier Luigi Zinzani, Federico Caligaris‐Cappio, JF Seymour, A Berrébi, Ulrich Jäger, Bruno Cazin, Marek Trněný, Anne Westermann, C-M Wendtner, BF Eichhorst, Peter Staib, Andreas Bühler, Dirk Winkler, Thorsten Zenz, Sebastian Böttcher, Matthias Ritgen, Myriam Mendila, Michael Kneba, Hartmut Döhner, S. Stilgenbauer
The Lancet. 20101,874 Citations
Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Kirsten Fischer, Paula Cramer, Raymonde Busch, Sebastian Böttcher, Jasmin Bahlo, Jöerg Schubert, Karl Heinz Pflüger, Silke Schott, Valentin Goede, Susanne Isfort, Julia von Tresckow, Anna‐Maria Fink, Andreas Bühler, Dirk Winkler, Karl‐Anton Kreuzer, Peter Staib, Matthias Ritgen, Michael Kneba, Hartmut Döhner, Barbara Eichhorst, Michael Hallek, Stephan Stilgenbauer, Clemens‐Martin Wendtner
Journal of Clinical Oncology. 2012433 CitationsOPEN ACCESS
Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Kirsten Fischer, Paula Cramer, Raymonde Busch, Stephan Stilgenbauer, Jasmin Bahlo, Carmen D. Schweighofer, Sebastian Böttcher, Peter Staib, Michael Kiehl, Michael J. Eckart, Gabriele Kranz, Valentin Goede, Thomas Elter, Andreas Bühler, Dirk Winkler, Michael Kneba, Hartmut Döhner, Barbara Eichhorst, Michael Hallek, Clemens‐Martin Wendtner
Journal of Clinical Oncology. 2011375 Citations

How much of the research on Sankt-Antonius-Hospital Eschweiler is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
33%
Closed
67%

Related on ScholarIQ

470M+ articles · 14-day free trial